A Scaffold-Aware Machine Learning Docking Pipeline for TYK2 Inhibitor Discovery with Calibrated Prioritization of 32 Active Compounds Including Deucravacitinib. IRJMSS. 2025;6(4):42-55. Accessed February 12, 2026. https://irjmss.com/index.php/irjmss/article/view/484